ER proteostasis disturbances in Parkinson's disease: Novel insights

Frontiers in Aging Neuroscience

Volumn 7, Issue MAR, 2015, Pages

  Mercado, Gabriela ^a,b   Castillo, Valentina ^a,b   Vidal, Rene ^a,c   Hetz, Claudio ^a,b,d  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c Millennium Nucleus for Regenerative Biology and Neurounion Biomedical Foundation   (Chile)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Dopaminergic neurons; ER stress; Gene therapy; Parkinson disease; Preclinical models; UPR signaling pathways

Indexed keywords

ALPHA SYNUCLEIN; UNCOUPLING PROTEIN;

ARTICLE; CELL FATE; CELL LOSS; DOPAMINERGIC NERVE CELL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; LEWY BODY; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; SIGNAL TRANSDUCTION;

EID: 84926343690     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00039     Document Type: Article

References (32)

1. Boyce, M., Bryant, K. F., Jousse, C., Long, K., Harding, H. P., Scheuner, D., et al. (2005). A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307, 935-939. doi: 10.1126/science.1101902
2. Chua, C. E., and Tang, B. L. (2013). Linking membrane dynamics and trafficking to autophagy and the unfolded protein response. J. Cell. Physiol. 228, 1638-1640. doi: 10.1002/jcp.24341
3. Chung, C. Y., Khurana, V., Auluck, P. K., Tardiff, D. F., Mazzulli, J. R., Soldner, F., et al. (2013). Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342, 983-987. doi: 10.1126/science.1245296
4. Colla, E., Coune, P., Liu, Y., Pletnikova, O., Troncoso, J. C., Iwatsubo, T., et al. (2012). Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J. Neurosci. 32, 3306-3320. doi: 10.1523/JNEUROSCI.5367-11.2012
5. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., et al. (2006). Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328. doi: 10.1126/science.1129462
6. Coune, P. G., Bensadoun, J. C., Aebischer, P., and Schneider, B. L. (2011). Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease. J. Parkinsons Dis. 1, 373-387. doi: 10.3233/JPD-2011-11058
7. Coune, P. G., Schneider, B. L., and Aebischer, P. (2012). Parkinson's disease: gene therapies. Cold Spring Harb. Perspect. Med. 2:a009431. doi: 10.1101/cshperspect.a009431
8. Credle, J. J., Forcelli, P. A., Delannoy, M., Oaks, A. W., Permaul, E., Berry, D. L., et al. (2015). Alpha-synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease. Neurobiol. Dis. 76, 112-125. doi: 10.1016/j.nbd.2015.02.005
9. Egawa, N., Yamamoto, K., Inoue, H., Hikawa, R., Nishi, K., Mori, K., et al. (2011). The endoplasmic reticulum stress sensor, ATF6alpha, protects against neurotoxin-induced dopaminergic neuronal death. J. Biol. Chem. 286, 7947-7957. doi: 10.1074/jbc. M110.156430
10. Fouillet, A., Levet, C., Virgone, A., Robin, M., Dourlen, P., Rieusset, J., et al. (2012). ER stress inhibits neuronal death by promoting autophagy. Autophagy 8, 915-926. doi: 10.4161/auto.19716
11. Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, L. J., et al. (2008). The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. U.S.A. 105, 145-150. doi: 10.1073/pnas.0710685105
12. Gorbatyuk, M. S., Shabashvili, A., Chen, W., Meyers, C., Sullivan, L. F., Salganik, M., et al. (2012). Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol. Ther. 20, 1327-1337. doi: 10.1038/mt.2012.28
13. Halliday, M., Radford, H., and Mallucci, G. R. (2014). Prions: generation and spread versus neurotoxicity. J. Biol. Chem. 289, 9862-19868. doi: 10.1074/jbc. R114.568477
14. Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., et al. (2003). An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11, 619-633. doi: 10.1016/S1097-2765(03)00105-9
15. Hetz, C. (2012). The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89-102. doi: 10.1038/nrm3270
16. Hetz, C., Chevet, E., and Harding, H. P. (2013). Targeting the unfolded protein response in disease. Nat. Rev. Drug Discov. 12, 703-719. doi: 10.1038/nrd3976
17. Hetz, C., and Mollereau, B. (2014). Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15, 233-249. doi: 10.1038/nrn3689
18. Hetz, C., Thielen, P., Matus, S., Nassif, M., Court, F., Kiffin, R., et al. (2009). XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 23, 2294-2306. doi: 10.1101/gad.1830709
19. Hoozemans, J. J., van Haastert, E. S., Eikelenboom, P., de Vos, R. A., Rozemuller, J. M., and Scheper, W. (2007). Activation of the unfolded protein response in Parkinson's disease. Biochem. Biophys. Res. Commun. 354, 707-711. doi: 10.1016/j.bbrc.2007.01.043
20. Lihui, S., Tianmin, X., Fengzhang, W., Qun, L., and Manhua, C. (2012). X-box-binding protein 1-modified neural stem cells for treatment of Parkinson's disease. Neural Regen. Res. 7, 736-740. doi: 10.3969/j.issn.1673-5374.2012.10.003
21. Mardones, P., Martinez, G., and Hetz, C. (2015). Control of systemic proteostasis by the nervous system. Trends Cell Biol. 25, 1-10. doi: 10.1016/j.tcb.2014.08.001
22. Matus, S., Castillo, K., and Hetz, C. (2012). Hormesis: protecting neurons against cellular stress in Parkinson disease. Autophagy 8, 997-1001. doi: 10.4161/auto.20748
23. Mercado, G., Valdes, P., and Hetz, C. (2013). An ERcentric view of Parkinson's disease. Trends Mol. Med. 19, 165-175. doi: 10.1016/j.molmed.2012.12.005
24. Ray, A., Zhang, S., Rentas, C., Caldwell, K. A., and Caldwell, G. A. (2014). RTCB-1 mediates neuroprotection via XBP-1 mRNA splicing in the unfolded protein response pathway. J. Neurosci. 34, 16076-16085. doi: 10.1523/JNEUROSCI.1945-14.2014
25. Ron, D., and Walter, P. (2007). Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519-529. doi: 10.1038/nrm2199
26. Sado, M., Yamasaki, Y., Iwanaga, T., Onaka, Y., Ibuki, T., Nishihara, S., et al. (2009). Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Res. 1257, 16-24. doi: 10.1016/j.brainres.2008.11.104
27. Silva, R. M., Ries, V., Oo, T. F., Yarygina, O., Jackson-Lewis, V., Ryu, E. J., et al. (2005). CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J. Neurochem. 95, 974-986. doi: 10.1111/j.1471-4159.2005.03428.x
28. Urra, H., Dufey, E., Lisbona, F., Rojas-Rivera, D., and Hetz, C. (2013). When ER stress reaches a dead end. Biochim. Biophys. Acta 1833, 3507-3517. doi: 10.1016/j.bbamcr.2013.07.024
29. Valdes, P., Mercado, G., Vidal, R. L., Molina, C., Parsons, G., Court, F. A., et al. (2014). Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proc. Natl. Acad. Sci. U.S.A. 111, 6804-6809. doi: 10.1073/pnas.1321845111
30. Valenzuela, V., Collyer, E., Armentano, D., Parsons, G. B., Court, F. A., and Hetz, C. (2012). Activation of the unfolded protein response enhances motor recovery after spinal cord injury. Cell Death Dis. 3:e272. doi: 10.1038/cddis.2012.8
31. Vidal, R. L., Figueroa, A., Court, F. A., Thielen, P., Molina, C., Wirth, C., et al. (2012). Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy. Hum. Mol. Genet. 21, 2245-2262. doi: 10.1093/hmg/dds040
32. Zimprich, A., Benet-Pages, A., Struhal, W., Graf, E., Eck, S. H., Offman, M. N., et al. (2011). A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 89, 168-175. doi: 10.1016/j.ajhg.2011.06.008